Product information and disease descriptionPlace of product in therapyDisease description
Burden of Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
31 evidence topics · 31 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionPlace of product in therapyDisease description
31 evidence topics · 31 sources